Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ENDOLOGIX INC /DE/ELGX · Entity 146591 | Director | September 04, 2020 | September 17, 2020 |
| GLOBUS MEDICAL INCGMED · Entity 3496 | Director | January 21, 2026 | January 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ENDOLOGIX INC /DE/
Report date September 04, 2020 · Filed September 17, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2020-09-04 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2020-09-04 · Sale · Disposed 2,582 · Balance 49,262 Row 2 · 2020-09-04 · Sale · Disposed 33,709 · Balance 15,553 Row 3 · 2020-09-04 · Sale · Disposed 15,553 · Balance 0 |
GLOBUS MEDICAL INC
Report date January 21, 2026 · Filed January 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $94.15 · Expires 2036-01-21 | Direct | 15,000 |
Reported balance
After 2026-01-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-01-21 · Grant · Acquired 15,000 · Balance 15,000 F1: These options were granted on January 21, 2026, and will vest on January 1, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: These options were granted on January 21, 2026, and will vest on January 1, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 21, 2026 Filed Jan 23, 2026 16:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $94.15 | $0.00 |
DisclosureSEC source: 0001193125-26-021222 · ownership.xml · derivative · entry 1 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 15,000 shares Expires 2036-01-21 F1 · derivative.exercise_date: These options were granted on January 21, 2026, and will vest on January 1, 2027. Read SEC document |
| January 23, 2025 Filed Mar 28, 2025 19:09 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $92.42 | $0.00 |
DisclosureSEC source: 0000950170-25-047045 · ownership.xml · derivative · entry 1 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 15,000 shares Expires 2035-01-23 F1 · derivative.exercise_date: These options were granted on January 23, 2025, and will vest on January 1, 2026. Read SEC document |
| November 22, 2024 Filed Nov 25, 2024 16:31 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 1,097 | $0.00 Strike: $65.05 | $0.00 |
DisclosureSEC source: 0000950170-24-130597 · ownership.xml · derivative · entry 6 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 625 Underlying: Class A Common Stock · 1,097 shares Expires 2031-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options were granted on January 14, 2021 and are fully vested. Read SEC document |
| November 22, 2024 Filed Nov 25, 2024 16:31 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 1,097 | $85.02 | $93,263.21 |
DisclosureSEC source: 0000950170-24-130597 · ownership.xml · nonDerivative · entry 4 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.08, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| November 22, 2024 Filed Nov 25, 2024 16:31 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 1,097 | $65.05 | $71,359.85 |
DisclosureSEC source: 0000950170-24-130597 · ownership.xml · nonDerivative · entry 3 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,097 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 16:31 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 13,278 | $0.00 Strike: $65.05 | $0.00 |
DisclosureSEC source: 0000950170-24-130597 · ownership.xml · derivative · entry 5 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,722 Underlying: Class A Common Stock · 13,278 shares Expires 2031-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options were granted on January 14, 2021 and are fully vested. Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 16:31 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 13,278 | $85.00 | $1,128,630.00 |
DisclosureSEC source: 0000950170-24-130597 · ownership.xml · nonDerivative · entry 2 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 16:31 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 13,278 | $65.05 | $863,733.90 |
DisclosureSEC source: 0000950170-24-130597 · ownership.xml · nonDerivative · entry 1 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,278 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2024 Filed May 14, 2024 17:16 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 17,500 | $0.00 Strike: $53.27 | $0.00 |
DisclosureSEC source: 0000950170-24-059787 · ownership.xml · derivative · entry 7 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 17,500 shares Expires 2030-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options were granted on January 22, 2020 and are fully vested. Read SEC document |
| May 10, 2024 Filed May 14, 2024 17:16 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 17,500 | $0.00 Strike: $43.58 | $0.00 |
DisclosureSEC source: 0000950170-24-059787 · ownership.xml · derivative · entry 6 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 17,500 shares Expires 2029-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on January 22, 2019 and are fully vested. Read SEC document |
| May 10, 2024 Filed May 14, 2024 17:16 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 17,500 | $0.00 Strike: $43.77 | $0.00 |
DisclosureSEC source: 0000950170-24-059787 · ownership.xml · derivative · entry 5 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 17,500 shares Expires 2028-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on January 22, 2018 and are fully vested. Read SEC document |
| May 10, 2024 Filed May 14, 2024 17:16 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 63,300 | $64.61 | $4,090,021.89 |
DisclosureSEC source: 0000950170-24-059787 · ownership.xml · nonDerivative · entry 4 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.80 to $64.68, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| May 10, 2024 Filed May 14, 2024 17:16 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 17,500 | $53.27 | $932,225.00 |
DisclosureSEC source: 0000950170-24-059787 · ownership.xml · nonDerivative · entry 3 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2024 Filed May 14, 2024 17:16 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 17,500 | $43.58 | $762,650.00 |
DisclosureSEC source: 0000950170-24-059787 · ownership.xml · nonDerivative · entry 2 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2024 Filed May 14, 2024 17:16 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 17,500 | $43.77 | $765,975.00 |
DisclosureSEC source: 0000950170-24-059787 · ownership.xml · nonDerivative · entry 1 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 16:55 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $53.75 | $0.00 |
DisclosureSEC source: 0000950170-24-008931 · ownership.xml · derivative · entry 1 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 15,000 shares Expires 2034-01-26 F1 · derivative.exercise_date: These options were granted on January 26, 2024, and will vest on January 1, 2025. Read SEC document |
| May 15, 2023 Filed May 17, 2023 16:31 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 17,500 | $0.00 Strike: $26.27 | $0.00 |
DisclosureSEC source: 0001209191-23-030202 · doc4.xml · derivative · entry 9 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 17,500 shares Expires 2027-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 30, 2017 and are fully vested. Read SEC document |
| May 15, 2023 Filed May 17, 2023 16:31 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 14,000 | $0.00 Strike: $25.52 | $0.00 |
DisclosureSEC source: 0001209191-23-030202 · doc4.xml · derivative · entry 8 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 14,000 shares Expires 2026-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options were granted on January 25, 2016 and are fully vested. Read SEC document |
| May 15, 2023 Filed May 17, 2023 16:31 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 10,500 | $0.00 Strike: $24.10 | $0.00 |
DisclosureSEC source: 0001209191-23-030202 · doc4.xml · derivative · entry 7 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 10,500 shares Expires 2025-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on January 20, 2015 and are fully vested. Read SEC document |
| May 15, 2023 Filed May 17, 2023 16:31 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 1,450 | $0.00 Strike: $23.95 | $0.00 |
DisclosureSEC source: 0001209191-23-030202 · doc4.xml · derivative · entry 6 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 1,450 shares Expires 2024-01-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on January 23, 2014 and are fully vested. Read SEC document |
| May 15, 2023 Filed May 17, 2023 16:31 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 43,450 | $56.98 | $2,475,976.53 |
DisclosureSEC source: 0001209191-23-030202 · doc4.xml · nonDerivative · entry 5 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,800 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.77 to $57.215, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| May 15, 2023 Filed May 17, 2023 16:31 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 17,500 | $26.27 | $459,725.00 |
DisclosureSEC source: 0001209191-23-030202 · doc4.xml · nonDerivative · entry 4 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2023 Filed May 17, 2023 16:31 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 14,000 | $25.52 | $357,280.00 |
DisclosureSEC source: 0001209191-23-030202 · doc4.xml · nonDerivative · entry 3 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2023 Filed May 17, 2023 16:31 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 10,500 | $24.10 | $253,050.00 |
DisclosureSEC source: 0001209191-23-030202 · doc4.xml · nonDerivative · entry 2 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2023 Filed May 17, 2023 16:31 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 1,450 | $23.95 | $34,727.50 |
DisclosureSEC source: 0001209191-23-030202 · doc4.xml · nonDerivative · entry 1 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 16:31 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 5,550 | $0.00 Strike: $23.95 | $0.00 |
DisclosureSEC source: 0001209191-23-008737 · doc4.xml · derivative · entry 2 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,450 Underlying: Class A Common Stock · 5,550 shares Expires 2024-01-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options were granted on January 23, 2014 and are fully vested. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 16:31 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 5,550 | $23.95 | $132,922.50 |
DisclosureSEC source: 0001209191-23-008737 · doc4.xml · nonDerivative · entry 1 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2023 Filed Jan 30, 2023 16:34 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 5,250 | $0.00 Strike: $12.59 | $0.00 |
DisclosureSEC source: 0001209191-23-005484 · doc4.xml · derivative · entry 2 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 5,250 shares Expires 2023-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options were granted on January 30, 2013 and are fully vested. Read SEC document |
| January 27, 2023 Filed Jan 30, 2023 16:34 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 5,250 | $12.59 | $66,097.50 |
DisclosureSEC source: 0001209191-23-005484 · doc4.xml · nonDerivative · entry 1 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2023 Filed Feb 27, 2023 16:57 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $75.18 | $0.00 |
DisclosureSEC source: 0001209191-23-013232 · doc4.xml · derivative · entry 1 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 15,000 shares Expires 2033-01-26 F1 · derivative.exercise_date: These options were granted on January 26, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| August 25, 2022 Filed Jan 18, 2023 16:55 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | OtherStock Option (Right to Buy Class A Common Stock) · Derivative | 7,500 | $0.00 Strike: $53.27 | $0.00 |
DisclosureSEC source: 0001209191-23-003772 · doc4.xml · derivative · entry 8 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Class A Common Stock · 7,500 shares Expires 2030-01-22 F1 · kind: The option transfers reported in this Form 4 represent options to purchase Class A Common Stock that have been transferred to the reporting person's ex-spouse pursuant to an option transfer agreement in connection with a divorce settlement. The shares now owned by the ex-spouse are no longer beneficially owned by the reporting person. F9 · derivative.exercise_date: These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| August 25, 2022 Filed Jan 18, 2023 16:55 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | OtherStock Option (Right to Buy Class A Common Stock) · Derivative | 7,500 | $0.00 Strike: $43.58 | $0.00 |
DisclosureSEC source: 0001209191-23-003772 · doc4.xml · derivative · entry 7 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Class A Common Stock · 7,500 shares Expires 2029-01-22 F1 · kind: The option transfers reported in this Form 4 represent options to purchase Class A Common Stock that have been transferred to the reporting person's ex-spouse pursuant to an option transfer agreement in connection with a divorce settlement. The shares now owned by the ex-spouse are no longer beneficially owned by the reporting person. F8 · derivative.exercise_date: These options were granted on January 22, 2019 and are fully vested. Read SEC document |
| August 25, 2022 Filed Jan 18, 2023 16:55 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | OtherStock Option (Right to Buy Class A Common Stock) · Derivative | 7,500 | $0.00 Strike: $43.77 | $0.00 |
DisclosureSEC source: 0001209191-23-003772 · doc4.xml · derivative · entry 6 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Class A Common Stock · 7,500 shares Expires 2028-01-22 F1 · kind: The option transfers reported in this Form 4 represent options to purchase Class A Common Stock that have been transferred to the reporting person's ex-spouse pursuant to an option transfer agreement in connection with a divorce settlement. The shares now owned by the ex-spouse are no longer beneficially owned by the reporting person. F7 · derivative.exercise_date: These options were granted on January 22, 2018 and are fully vested. Read SEC document |
| August 25, 2022 Filed Jan 18, 2023 16:55 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | OtherStock Option (Right to Buy Class A Common Stock) · Derivative | 7,500 | $0.00 Strike: $26.27 | $0.00 |
DisclosureSEC source: 0001209191-23-003772 · doc4.xml · derivative · entry 5 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Class A Common Stock · 7,500 shares Expires 2027-01-30 F1 · kind: The option transfers reported in this Form 4 represent options to purchase Class A Common Stock that have been transferred to the reporting person's ex-spouse pursuant to an option transfer agreement in connection with a divorce settlement. The shares now owned by the ex-spouse are no longer beneficially owned by the reporting person. F6 · derivative.exercise_date: These options were granted on January 30, 2017 and are fully vested. Read SEC document |
| August 25, 2022 Filed Jan 18, 2023 16:55 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | OtherStock Option (Right to Buy Class A Common Stock) · Derivative | 6,000 | $0.00 Strike: $25.52 | $0.00 |
DisclosureSEC source: 0001209191-23-003772 · doc4.xml · derivative · entry 4 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Class A Common Stock · 6,000 shares Expires 2026-01-25 F1 · kind: The option transfers reported in this Form 4 represent options to purchase Class A Common Stock that have been transferred to the reporting person's ex-spouse pursuant to an option transfer agreement in connection with a divorce settlement. The shares now owned by the ex-spouse are no longer beneficially owned by the reporting person. F5 · derivative.exercise_date: These options were granted on January 25, 2016 and are fully vested. Read SEC document |
| August 25, 2022 Filed Jan 18, 2023 16:55 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | OtherStock Option (Right to Buy Class A Common Stock) · Derivative | 4,500 | $0.00 Strike: $24.10 | $0.00 |
DisclosureSEC source: 0001209191-23-003772 · doc4.xml · derivative · entry 3 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,500 Underlying: Class A Common Stock · 4,500 shares Expires 2025-01-20 F1 · kind: The option transfers reported in this Form 4 represent options to purchase Class A Common Stock that have been transferred to the reporting person's ex-spouse pursuant to an option transfer agreement in connection with a divorce settlement. The shares now owned by the ex-spouse are no longer beneficially owned by the reporting person. F4 · derivative.exercise_date: These options were granted on January 20, 2015 and are fully vested. Read SEC document |
| August 25, 2022 Filed Jan 18, 2023 16:55 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | OtherStock Option (Right to Buy Class A Common Stock) · Derivative | 3,000 | $0.00 Strike: $23.95 | $0.00 |
DisclosureSEC source: 0001209191-23-003772 · doc4.xml · derivative · entry 2 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Class A Common Stock · 3,000 shares Expires 2024-01-23 F1 · kind: The option transfers reported in this Form 4 represent options to purchase Class A Common Stock that have been transferred to the reporting person's ex-spouse pursuant to an option transfer agreement in connection with a divorce settlement. The shares now owned by the ex-spouse are no longer beneficially owned by the reporting person. F3 · derivative.exercise_date: These options were granted on January 23, 2014 and are fully vested. Read SEC document |
| August 25, 2022 Filed Jan 18, 2023 16:55 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | OtherStock Option (Right to Buy Class A Common Stock) · Derivative | 2,250 | $0.00 Strike: $12.59 | $0.00 |
DisclosureSEC source: 0001209191-23-003772 · doc4.xml · derivative · entry 1 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Class A Common Stock · 2,250 shares Expires 2023-01-30 F1 · kind: The option transfers reported in this Form 4 represent options to purchase Class A Common Stock that have been transferred to the reporting person's ex-spouse pursuant to an option transfer agreement in connection with a divorce settlement. The shares now owned by the ex-spouse are no longer beneficially owned by the reporting person. F2 · derivative.exercise_date: These options were granted on January 30, 2013 and are fully vested. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 16:55 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $63.68 | $0.00 |
DisclosureSEC source: 0001209191-22-005607 · doc4.xml · derivative · entry 1 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 15,000 shares Expires 2032-01-27 F1 · derivative.exercise_date: These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 16:39 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 15,384 | $0.00 Strike: $11.28 | $0.00 |
DisclosureSEC source: 0001209191-21-019789 · doc4.xml · derivative · entry 3 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 15,384 shares Expires 2021-04-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Initially the stock option provided a right to buy the Company's Class C Common Stock. Upon the closing of the Company's initial public offering, all shares of the Company's Class C Common Stock automatically converted into shares of the Company's Class A Common Stock on a one-for-one basis. As a result, this stock option automatically converted into a right to buy the Company's Class A Common Stock. F3 · derivative.exercise_date: These options were granted on April 20, 2011 and are fully vested. F2 · derivative.underlying: Initially the stock option provided a right to buy the Company's Class C Common Stock. Upon the closing of the Company's initial public offering, all shares of the Company's Class C Common Stock automatically converted into shares of the Company's Class A Common Stock on a one-for-one basis. As a result, this stock option automatically converted into a right to buy the Company's Class A Common Stock. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 16:39 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 15,384 | $62.47 | $961,038.48 |
DisclosureSEC source: 0001209191-21-019789 · doc4.xml · nonDerivative · entry 2 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.12 to $62.70, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 16:39 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 15,384 | $11.28 | $173,531.52 |
DisclosureSEC source: 0001209191-21-019789 · doc4.xml · nonDerivative · entry 1 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,384 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 14, 2021 Filed Jan 19, 2021 17:01 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $65.05 | $0.00 |
DisclosureSEC source: 0001209191-21-004051 · doc4.xml · derivative · entry 1 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 15,000 shares Expires 2031-01-14 F1 · derivative.exercise_date: These options were granted on January 14, 2021, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2022, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| September 04, 2020 Filed Sep 17, 2020 16:35 UTC | ENDOLOGIX INC /DE/ ELGX · Entity 146591 | SaleCommon Stock | 15,553 | $0.05 | $810.31 |
DisclosureSEC source: 0001013606-20-000175 · wf-form4_160037493728657.xml · nonDerivative · entry 3 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| September 04, 2020 Filed Sep 17, 2020 16:35 UTC | ENDOLOGIX INC /DE/ ELGX · Entity 146591 | SaleCommon Stock | 33,709 | $0.05 | $1,688.82 |
DisclosureSEC source: 0001013606-20-000175 · wf-form4_160037493728657.xml · nonDerivative · entry 2 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,553 Read SEC document |
| September 04, 2020 Filed Sep 17, 2020 16:35 UTC | ENDOLOGIX INC /DE/ ELGX · Entity 146591 | SaleCommon Stock | 2,582 | $0.05 | $129.10 |
DisclosureSEC source: 0001013606-20-000175 · wf-form4_160037493728657.xml · nonDerivative · entry 1 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,262 Read SEC document |
| August 14, 2020 Filed Aug 19, 2020 19:58 UTC | ENDOLOGIX INC /DE/ ELGX · Entity 146591 | SaleCommon Stock | 1,127 | $0.08 | $91.96 |
DisclosureSEC source: 0001013606-20-000173 · wf-form4_159788148210714.xml · nonDerivative · entry 2 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,844 Read SEC document |
| August 13, 2020 Filed Aug 19, 2020 19:58 UTC | ENDOLOGIX INC /DE/ ELGX · Entity 146591 | SaleCommon Stock | 1,126 | $0.09 | $98.41 |
DisclosureSEC source: 0001013606-20-000173 · wf-form4_159788148210714.xml · nonDerivative · entry 1 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,971 Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 16:46 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 25,000 | $0.00 Strike: $53.27 | $0.00 |
DisclosureSEC source: 0001209191-20-004864 · doc4.xml · derivative · entry 1 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Class A Common Stock · 25,000 shares Expires 2030-01-22 F1 · derivative.exercise_date: These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 16:29 UTC | ENDOLOGIX INC /DE/ ELGX · Entity 146591 | GrantOption to Purchase · Derivative | 2,834 | Not disclosed Strike: $4.71 | Not disclosed |
DisclosureSEC source: 0001013606-19-000167 · wf-form4_156996175134943.xml · derivative · entry 4 Lemaitre Dan · CIK 0001478479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,834 Underlying: Common Stock · 2,834 shares Expires 2026-09-10 F5 · shares: The options vest in three equal annual installments over a three-year period commencing on September 10, 2019. F2 · price: The issuer cancelled, pursuant to the issuer's option exchange program which expired on September 9, 2019, (i) an option for 5,000 shares of common stock granted to the reporting person on December 10, 2009, (ii) an option for 2,000 shares of common stock granted to the reporting person on May 20, 2010, and (iii) an option for 2,000 shares of common stock granted to the reporting person on May 25, 2011. In exchange, the reporting person received a new stock option, for 2,834 shares, having an exercise price of $4.71 per share, which is equal to the closing price per share of the common stock on the NASDAQ Global Market on September 10, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.